Sassicaia Capital Advisers LLC Lyra Therapeutics, Inc. Transaction History
Sassicaia Capital Advisers LLC
- $27.6 Billion
- Q1 2025
A detailed history of Sassicaia Capital Advisers LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Sassicaia Capital Advisers LLC holds 10,000 shares of LYRA stock, worth $67,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$67,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LYRA
# of Institutions
46Shares Held
23.9MCall Options Held
56.6KPut Options Held
33.9K-
Perceptive Advisors LLC New York, NY12.8MShares$85.5 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$19 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.39MShares$9.31 Million0.08% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$7.09 Million0.02% of portfolio
-
Adar1 Capital Management, LLC Austin, TX533KShares$3.57 Million0.01% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $213M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...